US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)
Kathryn A. Phillips, Julia R. Trosman, Michael P. Douglas, Bruce D. Gelb, Bart S. Ferket, Lucia A. Hindorff, Anne Slavotinek, Jonathan S. Berg, Heidi V. Russell, Beth Devine, Veronica Greve, Hadley Stevens Smith
Topics & Concepts
Exome sequencingExcellenceExomeTransparency (behavior)Data scienceComputer scienceBiologyGeneticsPolitical scienceGeneLawMutationComputer securityGenomics and Rare DiseasesBRCA gene mutations in cancerHealth Systems, Economic Evaluations, Quality of Life